Rattlesnake Blood Protein Shows Promise Against Venom
Scientists found rattlesnake blood proteins can neutralise venom in mice, showing potential for developing more potent treatments for snakebite.
173 stories, newest first.
Scientists found rattlesnake blood proteins can neutralise venom in mice, showing potential for developing more potent treatments for snakebite.
Reading for pleasure is linked to better mental health, greater empathy and a lower risk of dementia, according to Cambridge University researchers.
The FDA held a public hearing on psychedelic therapies, with experts calling for safety standards, trained providers, patient screening and follow-up care.
A study finds climate change and shifting monsoon patterns could increase dengue risk in Kerala, with cases potentially rising by 20% by 2040.
Pennsylvania officials report a fourth measles-associated death as the state records over 600 cases this year amid a wider US measles surge.
Feeling guilty about taking a sick day may be linked to workplace culture, work identity and fear of being judged, experts say.
NOTTO data shows women made up 63.8% of living organ donors while men accounted for 69.8% of transplant recipients in India from 2019 to 2023.
IMA Haryana has withdrawn its planned indefinite suspension of Ayushman Bharat services after CM Nayab Singh Saini assured action on hospital concerns.
CDSCO has warned against unauthorised Pakistani whitening creams sold in India, citing excessive heavy metals and potential health risks.
A clinical trial found that a dual stellate ganglion block may reduce anxiety symptoms in patients who do not respond to standard treatments.
The BRICS Healthy Lifestyle Mission highlights prevention, nutrition and healthier communities as India faces changing health risks and lifestyle-related challenges.
Dr Reddy’s enters India’s biosimilar immuno-oncology market with Nivorz, a biosimilar of nivolumab, developed and manufactured at its Hyderabad facility.
Aurobindo Pharma has received final U.S. FDA approval to manufacture and market Beclomethasone Dipropionate HFA Inhalation Aerosol in 40 mcg and 80 mcg strengths. The generic asthma inhaler is equivalent to QVAR and is intended for the maintenance treatment of asthma. The product will be manufactured at the company’s subsidiary Aurolife Pharma’s facility in Raleigh, North Carolina, and is expected